Ligand Pharmaceuticals
LGND
LGND
251 hedge funds and large institutions have $2.71B invested in Ligand Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 113 increasing their positions, 71 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
8% more funds holding
Funds holding: 233 → 251 (+18)
58% less call options, than puts
Call options by funds: $3.61M | Put options by funds: $8.65M
Holders
251
Holding in Top 10
12
Calls
$3.61M
Puts
$8.65M
Top Buyers
| 1 | +$80.3M | |
| 2 | +$44M | |
| 3 | +$31M | |
| 4 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$17.4M |
| 5 |
CWAM
Columbia Wanger Asset Management
Chicago,
Illinois
|
+$16.9M |
Top Sellers
| 1 | -$19.8M | |
| 2 | -$19M | |
| 3 | -$18.1M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$14.5M |
| 5 |
Renaissance Technologies
New York
|
-$6.16M |